Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1146508.RAp9cVZ7s3otch4yvyw2JxrbfmxvydeD7Rpo926Sjtq2o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1146508.RAp9cVZ7s3otch4yvyw2JxrbfmxvydeD7Rpo926Sjtq2o130_assertion type Assertion NP1146508.RAp9cVZ7s3otch4yvyw2JxrbfmxvydeD7Rpo926Sjtq2o130_head.
- NP1146508.RAp9cVZ7s3otch4yvyw2JxrbfmxvydeD7Rpo926Sjtq2o130_assertion description "[We conducted a perspective study to investigate whether the expression of excision repair cross-complementing 1 (ERCC1), xeroderma pigmentosum group G (XPG), breast cancer 1 (BRCA1), and ribonucleotide reductase M1 (RRM1) is correlated with clinical outcome of non-small cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1146508.RAp9cVZ7s3otch4yvyw2JxrbfmxvydeD7Rpo926Sjtq2o130_provenance.
- NP1146508.RAp9cVZ7s3otch4yvyw2JxrbfmxvydeD7Rpo926Sjtq2o130_assertion evidence source_evidence_literature NP1146508.RAp9cVZ7s3otch4yvyw2JxrbfmxvydeD7Rpo926Sjtq2o130_provenance.
- NP1146508.RAp9cVZ7s3otch4yvyw2JxrbfmxvydeD7Rpo926Sjtq2o130_assertion SIO_000772 24443257 NP1146508.RAp9cVZ7s3otch4yvyw2JxrbfmxvydeD7Rpo926Sjtq2o130_provenance.
- NP1146508.RAp9cVZ7s3otch4yvyw2JxrbfmxvydeD7Rpo926Sjtq2o130_assertion wasDerivedFrom befree-2016 NP1146508.RAp9cVZ7s3otch4yvyw2JxrbfmxvydeD7Rpo926Sjtq2o130_provenance.
- NP1146508.RAp9cVZ7s3otch4yvyw2JxrbfmxvydeD7Rpo926Sjtq2o130_assertion wasGeneratedBy ECO_0000203 NP1146508.RAp9cVZ7s3otch4yvyw2JxrbfmxvydeD7Rpo926Sjtq2o130_provenance.